Sentence examples for full efficacy from inspiring English sources

Obtained results highlighted the full efficacy of the proposed model in supporting ex-ante feasibility studies.

Stennicke, H. R. et al. A novel B-domain O-glycoPEGylated FVIII (N8-GP) demonstrates full efficacy and prolonged effect in hemophilic mice models.

SAR studies indicated that electron-withdrawing substituents on the phenyl ring are important for potency and full efficacy.

Even though highly attenuated in presence of microRNA-7, this virus retained full efficacy against glioblastoma xenografts.

The ads, for Adams Flea and Tick Spot On for Dogs, sold by Farnam, included claims that the product "starts to kill fleas and ticks in 15 minutes"; the division said the evidence provided by Farnam showed the product reached full efficacy seven days after application.

Although the window of opportunity to initiate hypothermic treatment as well as the duration of cooling to achieve full efficacy may vary, the success or failure of therapeutic hypothermia treatment is dependent on the following four key factors [24],[15]: 1. Rate of cooling - rapid initiation of cooling immediately after injury resulted in better outcomes in animal studies.

Success of the pilot study will result in an application for a full-efficacy trial.

Full protective efficacy from the vaccine (maximum published efficacies) is assumed to begin after the booster dose.

While Caucasian men present with 60 70% suppression to azoospermia, the prerequisite for full contraceptive efficacy, reports from China have shown contraceptive efficacy rates of >90% (15, 16).

Previous work using 447e showed that DNA/PBAE nanoparticles lyophilized with sucrose as a protectant retained full transfection efficacy after being stored for 3 months at 4 °C, although efficacy decreased to ∼50% after 6 months of storage.

Compound 5b exhibited low-nanomolar in vitro binding affinity (IC50 = 5.8 nM), excellent selectivity for the δ opioid receptor over the alternative μ and κ opioid receptors, full agonist efficacy in receptor down-regulation and MAP kinase activation assays, and low-efficacy partial agonist activity in stimulation of GTPγS binding.